|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.30 SEK | -1.54% |
|
-2.23% | +32.43% |
| 12:23pm | Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal | FW |
| 01/07 | SB1 reiterates Buy on Asmodee, discount to peers is hard to justify | FW |
Company Valuation: Asmodee
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 1,971 | 2,265 | 3,053 | - | - |
| Change | - | 14.91% | 34.78% | - | - |
| Enterprise Value (EV) 1 | 2,381 | 2,522 | 3,489 | 3,349 | 3,179 |
| Change | - | 5.95% | 38.33% | -4.02% | -5.08% |
| P/E | 307x | 82.6x | 21x | 20.2x | 17.8x |
| PBR | 1.05x | 1.21x | 1.54x | 1.44x | 1.36x |
| PEG | - | 0x | 0x | 4.79x | 1.3x |
| Capitalization / Revenue | 1.44x | 1.35x | 1.65x | 1.65x | 1.58x |
| EV / Revenue | 1.74x | 1.5x | 1.88x | 1.81x | 1.64x |
| EV / EBITDA | 10.4x | 8.84x | 10.6x | 10x | 9.06x |
| EV / EBIT | 12x | 9.8x | 11.8x | 11.4x | 10.3x |
| EV / FCF | 14.2x | 12x | 18.9x | 16x | 14.4x |
| FCF Yield | 7.07% | 8.31% | 5.29% | 6.23% | 6.95% |
| Dividend per Share 3 | - | 1.848 | 1.848 | 1.911 | 2.189 |
| Rate of return | - | 1.74% | 1.3% | 1.34% | 1.54% |
| EPS 3 | 0.2982 | 1.287 | 6.77 | 7.055 | 7.988 |
| Distribution rate | - | 144% | 27.3% | 27.1% | 27.4% |
| Net sales 1 | 1,369 | 1,684 | 1,854 | 1,848 | 1,934 |
| EBITDA 1 | 228.2 | 285.4 | 330 | 333.7 | 350.8 |
| EBIT 1 | 198.2 | 257.3 | 294.8 | 293.4 | 309.6 |
| Net income 1 | 4.699 | 27.7 | 149.4 | 156.3 | 180.8 |
| Net Debt 1 | 409.8 | 257.5 | 436.4 | 296.2 | 126.1 |
| Reference price 3 | 91.50 | 106.34 | 142.50 | 142.50 | 142.50 |
| Nbr of stocks (in thousands) | 2,33,692 | 2,33,692 | 2,36,721 | - | - |
| Announcement Date | 21/05/25 | 21/05/26 | - | - | - |
1SEK in Million2EUR in Million3SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.05x | 1.88x | 10.57x | 1.3% | 348.82Cr | ||
| 20.46x | 2.68x | 15.26x | 2.82% | 5.09TCr | ||
| 16.65x | 8.27x | 14x | 5.41% | 675.17Cr | ||
| 15.78x | 0.75x | 6.24x | 2.32% | 174.98Cr | ||
| 13.03x | 2.03x | 7.43x | 1.95% | 154.98Cr | ||
| 27.29x | - | - | - | 32Cr | ||
| 7.57x | 4.18x | 6.2x | 4.1% | 8.72Cr | ||
| Average | 17.40x | 3.30x | 9.95x | 2.98% | 926.4Cr | |
| Weighted average by Cap. | 19.80x | 3.15x | 14.43x | 2.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ASMDEE B Stock
- Valuation Asmodee
Select your edition
All financial news and data tailored to specific country editions
















